US Patent Issued to Halda Therapeutics OpCo on Feb. 24 for "Heterobifunctional compounds and their use in treating disease" (Connecticut Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,428, issued on Feb. 24, was assigned to Halda Therapeutics OpCo Inc. (New Haven, Conn.).

"Heterobifunctional compounds and their use in treating disease" was invented by Kyle J. Eastman (Killingworth, Conn.), Katherine J. Kayser-Bricker (Branford, Conn.), James John Mousseau (Salem, Conn.), Matthew Alexander Perry (Uncasville, Conn.), David E. Puleo (Fairfield, Conn.) and Samuel W. Gerritz (Guilford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides heterobifunctional compounds, pharmaceutical compositions, and their use in treating disease, such as cancer."

The patent was filed on March 7, 2025, under Application No. 19/0...